Clearmind Medicine receives approval to continue phase I trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. BE
3. PANW
4. CL
5. SNDK
6. TAP
7. DELL
8. ROIV
9. LAD
10. TTE

Go back to Clearmind Medicine receives approval to continue phase I trial
(NASDAQ: CMND) Delayed: 1.16 --0 (-0%)
Previous Close $1.16    52 Week High $ 
Open $1.16    52 Week Low $ 
Day High $1.16    P/E N/A 
Day Low $1.16    EPS $ 
Volume 51,820